InvestorsHub Logo
icon url

Amatuer17

05/19/20 7:01 AM

#78835 RE: All-Bidness #78830

“Cytodyn it will be coordinating with the NIH of Mexico and providing leronlimab for a trial for the severe/critical COVID-19 population in Mexico with the potential to collaborate on further CytoDyn COVID-19 trials.

This is a very good development. The local politics can give GILD an upper hand but possibly only trial in Mexico and very large concentrated population, the trial can move fast and local politicians will push results to show their contribution.
This can definitely put pressure in home market.

Saw news that Brazil became 3rd largest infected country and India numbers are going up very fast. Another 2 countries the trials can go.
However India is tricky as GILD gave India approval to mfr Rem as generic